EMP3 as a prognostic biomarker correlates with EMT in GBM

Author:

Li Li1,xia siyu1,Zhao Zitong1,Deng Lili1,wang hanbing1,yang dongbo1,Hu Yizhou2,Ji Jingjing1,Huang Dayong1,Xin Tao1

Affiliation:

1. the Second Affiliated Hospital of Harbin Medical University

2. Karolinska Institutet

Abstract

Abstract Background: Glioblastoma (GBM) is the most aggressive malignant central nervous system tumor with a poor prognosis.The malignant transformation of glioma cells via epithelial-mesenchymal transition (EMT) has been observed as a main obstacle for glioblastoma treatment.Epithelial membrane protein 3 (EMP3) is significantly associated with the malignancy of GBM and the prognosis of patients. Therefore, exploring the possible mechanisms by which EMP3promotes the proliferation of GBM has important implications for the treatment of GBM. Methods: We performed enrichment and correlation analysis in 5 single-cell RNA sequencing datasets. Differential expression of EMP3 in gliomas, Kaplan-Meier survival curves, diagnostic accuracy and prognostic prediction were analyzed by bioinformatics in the China Glioma Genome Atlas (CGGA) database and The Cancer Genome Atlas (TCGA) database. EMP3-silenced U87 and U251 cell lines were obtained by transient transfection with siRNA. The effect of EMP3 on glioblastoma proliferation was examined using the CCK-8 assay. Transwell migration assay and wound healing assay were used to assess the effect of EMP3on glioblastoma migration. Finally, quantitative real-time polymerase chain reaction(qRT-PCR)was used to detect the mRNA expression levels of EMT-related transcription factors and mesenchymal markers. Results: EMP3is a EMT associated gene in multiple types of malignant cancer and in high-grade glioblastoma. EMP3 is enriched in high-grade gliomas and isocitrate dehydrogenase (IDH) wild-type gliomas.EMP3 can be used as a specific biomarker for diagnosing glioma patients. It is also an independent prognostic factor for glioma patients' overall survival (OS). In addition, silencing EMP3 reduces the proliferation, migration and invasion of glioblastoma cells. Mechanistically, EMP3 enhances the malignant potential of tumor cells by promoting EMT. Conclusion: EMP3promotes the growth and invasion of GBM cells, and the mechanism may be related to EMP3 promoting the EMT process in GBM; EMP3 may be an independent prognostic factor in GBM.

Publisher

Research Square Platform LLC

Reference33 articles.

1. CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma;Maggs L;Front Neurosci,2021

2. Section: Neurosurgery Bioinformatics Analysis Reveals that IGFBP2, EMP3, PDPN, and MCUB Genes were Potential Biomarkers for Glioblastoma;Luo X;Int J Contemp Med Res,2020

3. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016;Ostrom QT;Neuro Oncol,2019

4. Disruption of the tumour-associated EMP3 enhances erythroid proliferation and causes the MAM-negative phenotype;Thornton N;Nat Commun,2020

5. EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer;Wang YW;Biochim Biophys Acta Rev Cancer,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3